ICL And Lavie Bio Leverage AI To Make Significant Advancement In Development Of Yield Increasing Bio-Stimulants
ICL And Lavie Bio Leverage AI To Make Significant Advancement In Development Of Yield Increasing Bio-Stimulants
More than one dozen novel microbes identified for row crops suffering from extreme weather conditions
爲遭受極端天氣條件影響的行作物識別了十幾種新型微生物。
TEL AVIV and REHOVOT, Israel, July 17, 2024 /PRNewswire/ -- ICL (NYSE:ICL) (TASE: ICL), a leading global specialty minerals company, and Lavie Bio Ltd., a leading ag-biologicals company and subsidiary of Evogene Ltd. (NASDAQ:EVGN) (TASE: EVGN), today announced a significant milestone in their collaboration to develop bio-stimulant solutions for key row crops facing various abiotic stresses. By leveraging artificial intelligence (AI), Lavie Bio has computationally identified more than a dozen novel microbial candidates believed to have commercial viability as bio-stimulants for crops grown under extreme weather conditions, including drought. While this process can normally take several years, the collaboration achieved success within its first 12 months – thanks to Lavie Bio's proprietary Biology Driven Design (BDD) technology platform.
以色列特拉維夫和雷霍沃特，2024年7月17日/ PRNewswire / - 全球領先的專業礦物質公司ICL（紐約證交所：ICL）（TASE：ICL）與領先的農業生物技術公司兼Evogene Ltd.（納斯達克：EVGN）（TASE：EVGN）的子公司Lavie Bio Ltd.宣佈了一個重大里程碑，即合作開發應對各種生物壓力的關鍵作物的生物促進溶液。通過利用人工智能（AI），Lavie Bio已計算出十幾種新微生物候選人，認爲在極端天氣條件下生長的作物中有商業可行性，包括乾旱地區。儘管這個過程通常需要幾年時間，但在第一個12個月內，合作取得了成功，這要歸功於Lavie Bio的專有生物驅動設計（BDD）技術平台。
